Qianjiang Yongan Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002365.SZ

Qianjiang Yongan Pharmaceutical Co., Ltd. Inventory for the year ending December 31, 2023: USD 9.84 M

Qianjiang Yongan Pharmaceutical Co., Ltd. Inventory is USD 9.84 M for the year ending December 31, 2023, a -54.59% change year over year. Inventory is the value of goods held by a company for sale or used in the production process.
  • Qianjiang Yongan Pharmaceutical Co., Ltd. Inventory for the year ending December 31, 2022 was USD 21.68 M, a -5.51% change year over year.
  • Qianjiang Yongan Pharmaceutical Co., Ltd. Inventory for the year ending December 31, 2021 was USD 22.94 M, a 83.37% change year over year.
  • Qianjiang Yongan Pharmaceutical Co., Ltd. Inventory for the year ending December 31, 2020 was USD 12.51 M, a -16.33% change year over year.
  • Qianjiang Yongan Pharmaceutical Co., Ltd. Inventory for the year ending December 31, 2019 was USD 14.95 M, a 5.63% change year over year.
Key data
Date Inventory Goodwill Total Assets Current Liabilities
Market news
Loading...
SV Wall Street
Shenzhen Stock Exchange: 002365.SZ

Qianjiang Yongan Pharmaceutical Co., Ltd.

CEO Mr. Rengui Hong
IPO Date March 5, 2010
Location China
Headquarters No. 2 Guangze Avenue
Employees 887
Sector Industrials
Industries
Description

Qianjiang Yongan Pharmaceutical Co., Ltd. manufactures and sells taurine in China. The company was founded in 2001 and is based in Qianjiang, China.

Similar companies

002332.SZ

Zhejiang Xianju Pharmaceutical Co.,Ltd.

USD 1.36

0.82%

002370.SZ

Zhejiang Yatai Pharmaceutical Co., Ltd.

USD 0.45

0.21%

002294.SZ

Shenzhen Salubris Pharmaceuticals Co., Ltd.

USD 4.11

-0.16%

002349.SZ

Jinghua Pharmaceutical Group Co., Ltd.

USD 1.01

0.04%

StockViz Staff

February 2, 2025

Any question? Send us an email